Egypt achieves significant savings on drug bill thanks to local insulin production
The relevant authorities in Egypt have announced a major achievement in the health sector, as the country has succeeded in significantly reducing its medicine import bill over the recent period. This development comes thanks to an increasing reliance on manufacturing insulin within Egyptian factories instead of importing it from abroad.
This step is based on a national strategy aimed at localizing the pharmaceutical industry and saving the hard currency that was previously spent on importing vital medicines. The commencement of local insulin production has led to a reduced reliance on foreign companies, which has contributed to the stable availability of this essential medication for diabetic patients across the country.
Reports issued by the trade federation indicate that this initiative has contributed to cutting the country's annual drug bill by nearly half. This financial saving allows the government to redirect financial resources toward improving other health services and developing public hospitals to better serve citizens.
This step is part of broader efforts being made by Egypt to strengthen its economic independence in the medical sector. It is expected that this trend will continue in the coming years to include other types of vital medicines, thereby enhancing the Egyptian health system's ability to face challenges and provide treatment at affordable prices for all patients.